Kallikrein‐8 inhibition attenuates Alzheimer's disease pathology in mice
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Introduction: Memory loss and increased anxiety are clinical hallmarks of Alzheimer's disease (AD). Kallikrein‐8 is a protease implicated in memory acquisition and anxiety, and its mRNA is known to be up‐regulated in AD‐affected human hippocampus. Therefore, an involvement of Kallikrein‐8 in Alzheimer's pathogenesis is conceivable but remains to be proved. Methods: We determined the cerebral expression of Kallikrein‐8 mRNA and protein during the course of AD in patients and in transgenic mice and tested the impact of Kallikrein‐8 inhibition on AD‐related pathology in mice and in primary glial cells. Results: Kallikrein‐8 mRNA and protein were up‐regulated in both species at incipient stages of AD. Kallikrein‐8 inhibition impeded amyloidogenic amyloid‐precursor‐protein processing, facilitated amyloid β (Aβ) clearance across the blood‐brain‐barrier, boosted autophagy, reduced Aβ load and tau pathology, enhanced neuroplasticity, reversed molecular signatures of anxiety, and ultimately improved memory and reduced fear. Discussion: Kallikrein‐8 is a promising new therapeutic target against AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
Autophagy and apoptosis dysfunction in neurodegenerative disorders
Ghavami, S., Shojaei, S., Yeganeh, B., Ande, S. R., Jangamreddy, J. R., Mehrpour, M., Christoffersson, J., Chaabane, W., Moghadam, A. R., Kashani, H. H., et al. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.10.004 · Cited by 1,039 · cited 2×
“Given that all the aforementioned behavioral, molecular, and structural processes, that is, anxiety and cognition, neuronal [9,10], and vascular [11,12] plasticity, as well as autophagy [13,14] are also impaired in Alzheimer’s disease (AD) patients and transgenic mice, it seems likely that KLK8/EPHB2 signaling could b…”
BackgroundChishti, M. A., Yang, D.-S., Janus, C., Phinney, A. L., Horne, P., Pearson, J., Strome, R., Zuker, N., Loukides, J., French, J., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100710200 · Cited by 955 · cited 1×
“Murine samples Female TgCRND8 mice (hemizygously carrying and over-expressing a double-mutant human APP 695 transgene [hAPP1/2] harboring the “Swedish” and “Indiana” mutations [KM670/671NL & V717F] under the control of the hamster Prion protein promoter) [20] as well as wildtype littermates from the hybrid C57BL/6-C3H…”
BackgroundOverexpression of Atg5 in mice activates autophagy and extends lifespan
Pyo, J.-O., Yoo, S.-M., Ahn, H.-H., Nah, J., Hong, S.-H., Kam, T.-I., Jung, S., & Jung, Y.-K. (2013) · Nature Communications · doi:10.1038/ncomms3300 · Cited by 721 · cited 1×
“The next step was to assess the protein levels of beclin-1, ATG5 (essential for the autophagosome assembly [32]) and STX17 in anti-KLK8 antibody versus IgG-treated mice.”
BackgroundKrabbe, G., Halle, A., Matyash, V., Rinnenthal, J. L., Eom, G. D., Bernhardt, U., Miller, K. R., Prokop, S., Kettenmann, H., & Heppner, F. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060921 · Cited by 478 · cited 1×
“A genotype-specific difference in basal autophagy and Ab phagocytosis efficacy could not be detected in primary glia (data not shown), supporting the data of previous publications that microglial functional impairment coincides with amyloid deposition and does not precede it [36].”
ResultReversing EphB2 depletion rescues cognitive functions in Alzheimer model
Cissé, M., Halabisky, B., Harris, J., Devidze, N., Dubal, D. B., Sun, B., Orr, A., Lotz, G., Kim, D. H., Hamto, P., et al. (2011) · Nature · doi:10.1038/nature09635 · Cited by 433 · cited 2×
“Lentivirus-mediated EPHB2 up-regulation improves cognition [18] and ligand-triggered EPHB2 activation diminishes tau phosphorylation [19] in transgenic mice.”
BackgroundYang, D.-S., Stavrides, P., Mohan, P. S., Kaushik, S., Kumar, A., Ohno, M., Schmidt, S. D., Wesson, D., Bandyopadhyay, U., Jiang, Y., et al. (2011) · Brain · doi:10.1093/brain/awq341 · Cited by 429 · cited 2×
“Given that all the aforementioned behavioral, molecular, and structural processes, that is, anxiety and cognition, neuronal [9,10], and vascular [11,12] plasticity, as well as autophagy [13,14] are also impaired in Alzheimer’s disease (AD) patients and transgenic mice, it seems likely that KLK8/EPHB2 signaling could b…”
BackgroundCataldo, A. M., Barnett, J. L., Berman, S. A., Li, J., Quarless, S., Bursztajn, S., Lippa, C., & Nixon, R. A. (1995) · Neuron · doi:10.1016/0896-6273(95)90324-0 · Cited by 379
Lucin, K. M., O’Brien, C. E., Bieri, G., Czirr, E., Mosher, K. I., Abbey, R. J., Mastroeni, D. F., Rogers, J., Spencer, B., Masliah, E., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.06.046 · Cited by 374 · cited 1×
“Impaired Ab phagocytosis and dysfunctional beclin-1associated autophagy in the AD-affected brain is tightly linked to reduced microglial activity [35].”
Background
Cited by
Kiyota, T., Machhi, J., Lu, Y., Dyavarshetty, B., Nemati, M., Yokoyama, I., Mosley, R. L., & Gendelman, H. E. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.03.009 · Cited by 80
ADAMTS13 maintains cerebrovascular integrity to ameliorate Alzheimer-like pathology
Cao, Y., Xu, H., Zhu, Y., Shi, M.-J., Wei, L., Zhang, J., Cheng, S., Shi, Y., Tong, H., Kang, L., et al. (2019) · PLOS Biology · doi:10.1371/journal.pbio.3000313 · Cited by 31
“Analysis of the elimination of brain Aβ into plasma The efflux efficacy of brain-derived Aβ in blood was determined as described [38,39].”
MethodSelf-citationRetractedSanchez-Mendoza, E. H., Camblor-Perujo, S., Martins Nascentes-Melo, L., Dzyubenko, E., Fleischer, M., Silva de Carvalho, T., Schmitt, L.-I., Leo, M., Hagenacker, T., Herring, A., et al. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01927-0 · Cited by 27
Self-citation
Metadata
- Authors
- Herring, A., Münster, Y., Akkaya, T., Moghaddam, S., Deinsberger, K., Meyer, J., Zahel, J., Sanchez‐Mendoza, E., Wang, Y., Hermann, D. M., Arzberger, T., Teuber‐Hanselmann, S., & Keyvani, K.
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2016-06-18
- Volume
- 12
- Issue
- 12
- Pages
- 1273-1287
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W2559993415
- Cited by
- 48
- References
- 13
- FWCI
- 5.25
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Kallikrein‐8 inhibition attenuates Alzheimer's disease pathology in mice. https://app.cochat.ai/papers/10.1016/j.jalz.2016.05.006
- The paper
- Herring, A., Münster, Y., Akkaya, T., Moghaddam, S., Deinsberger, K., Meyer, J., Zahel, J., Sanchez‐Mendoza, E., Wang, Y., Hermann, D. M., Arzberger, T., Teuber‐Hanselmann, S., & Keyvani, K. (2016). Kallikrein‐8 inhibition attenuates Alzheimer's disease pathology in mice. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2016.05.006
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.